Avalo Therapeutics, Inc. (AVTX) SEC Filings & Financial Intelligence
Avalo Therapeutics, Inc. (AVTX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AVTX
CIK: 1534120
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerJeremiah Ward
Audit LocationJericho, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-11-06 | — | SCHEDULE 13G/A Filing | 0000315066-26-002939 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-11-05 | — | SCHEDULE 13G/A Filing | 0000315066-26-002679 | View SEC Doc Filr Page |
| 8-K | 2026-11-05 | 2026-11-05 | FORM 8-K | 0001104659-26-123079 | View SEC Doc Filr Page |
| S-3ASR | 2026-11-05 | — | S-3ASR | 0001104659-26-123072 | View SEC Doc Filr Page |
| 424B5 | 2026-11-05 | — | 424B5 | 0001104659-26-123069 | View SEC Doc Filr Page |
| 10-Q | 2026-11-05 | 2026-09-30 | 10-Q | 0001534120-26-000057 | View SEC Doc Filr Page |
| 8-K | 2026-11-05 | 2026-11-05 | 8-K | 0001534120-26-000056 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-10-29 | — | SCHEDULE 13G Filing | 0001493152-26-049273 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | 4 Filing | 0001707797-26-000017 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | 4 Filing | 0001677036-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | 4 Filing | 0002063957-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-16 | 4 Filing | 0001810417-26-000023 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-10 | 4 Filing | 0001810417-26-000021 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-08-28 | 4 Filing | 0001918845-26-000031 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | 4 Filing | 0001810417-26-000019 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | 4 Filing | 0001918845-26-000029 | View SEC Doc Filr Page |
| 144 | 2026-08-18 | — | 144 Filing | 0001950047-26-008317 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001950047-26-008276 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001950047-26-008273 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001950047-26-008220 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-097285 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001727492-26-000021 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001231919-26-000918 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000921895-26-002164 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001897612-26-000606 | View SEC Doc Filr Page |